Main | Why Determining Drug Dose in Urine is a Myth ยป

Friday, 03/06/2009 at 11:34 AM

Welcome to the Companion Blog for the Urine Drug Monitoring: Opioids Handbook


Welcome to UDM Solutions, the companion blog for the Urine Drug Monitoring: Opioids handbook. Everyone involved in the creation of this handbook is excited about the launch of this new site and the important topics to be covered.

When we were planning the companion site, we thought a blog would be a great way to get readers involved in some of the new ideas presented in the handbook. UDM as defined in the handbook is a comprehensive strategy for monitoring pharmacotherapy. There are many ideas and techniques being integrated to form the complete strategy, and there are many ways to bring them together in a way that is specific to your needs. This blog will provide a forum for the authors to elaborate on UDM and for readers to contribute to the discussion.

To give you an idea of what UDM is about and what you can anticipate reading on this blog, here is a quote from page 8 in the handbook that provides a very basic definition of the UDM strategy.

Urine Drug Monitoring (UDM) is an objective patient-specific pharmacotherapeutic monitoring strategy which logically combines practices and procedures employed in clinical drug trials with current prescribing practices. UDM is a single solution comprised of many complementary parts. Each component scientifically addresses a necessary piece of the drug monitoring equation.

The components of UDM are:

  • Laboratory Diagnostics
  • Clinical Pharmacology
  • Pharmacogenomics and Pharmacogenetics
  • Patient Assessment
  • Medical Informatics

Thanks for visiting this site. We look forward to hearing from you and responding to your comments in the posts ahead.

Posted in: UDM Handbook


TrackBack URL for this entry:

Listed below are links to weblogs that reference Welcome to the Companion Blog for the Urine Drug Monitoring: Opioids Handbook:


This is a nice publication. Thank you.

However, I am still looking for a solid and usable answer to the question, "What should be done by a primary physician when a patient intended to be on chronic opiates is using marijuana, especially when repeatedly positive on testing or outright admitting that marijuana use is ongoing?"

It is so common! For a primary care physician in most of the United States, it means the patient is able and willing to engage in a criminal activity which places him or her in regular proximity to situations in which diversion of the intended opiate would be more likely.

Medical boards don't answer the question directly or in adequate detail, but certainly seem to frown on using controlled substances chronically in such a patient whether or not the patient has evidence of a pain disorder which otherwise would be treated with opiates.

If such a patient cannot access another physician such as a pain specialist, should they simply not be treated chronically at all with controlled substances by the primary physician? What are the various strategies physicians use to deal with this problematic situation? If you add new articles to this site I would love to see a detailed analysis of these problems I raise, preferably one which presents both sides of the issue yet chooses one approach as preferable.

The comments to this entry are closed.

Urine Drug Monitoring: Opioids

Urine Drug Monitoring: Opioids

Get your FREE handbook:

who we are

UDMSolutions is the companion website for the Urine Drug Monitoring: Opioids handbook. The Urine Drug Monitoring (UDM) strategy presents new concepts and new challenges to the way clinicians scrutinize patient pharmacotherapy. We cover the latest developments impacting pharmacotherapy as they relate to UDM and encourage discussion about solutions.

Find out more about the experts contributing to this site


Dominion Diagnostics logo

Dominion Diagnostics
Clinical Urine Drug Monitoring Laboratory